Hemoglobin Evaluation by HPLC and Electrophoresis With Reflex to RBC Solubility
Ordering Recommendation
Preferred test to screen for hemoglobinopathies. May be used for follow up in individuals with a known hemoglobinopathy.
For hemoglobinopathy screening with reflex to molecular confirmation, see Hemoglobin Evaluation Reflexive Cascade (2005792).
New York DOH Approval Status
Specimen Required
Lavender (EDTA) or pink (K2EDTA).
Transport 5 mL whole blood in original tube (Min: 0.5 mL). Also acceptable: whole blood in an ARUP standard transport tube.
Refrigerated
Frozen or room temperature specimens.
Ambient: Unacceptable; Refrigerated: 1 week; Frozen: Unacceptable
Methodology
High Performance Liquid Chromatography (HPLC) / Capillary Electrophoresis / RBC Solubility
Performed
Sun-Sat
Reported
1-5 days
Reference Interval
| Test Number |
Components |
Reference Interval |
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hemoglobin Other | 0.0 | |||||||||||||||||||||
| Hemoglobin E | 0.0 | |||||||||||||||||||||
| Hemoglobin C | 0.0 | |||||||||||||||||||||
| Hemoglobin S | 0.0 | |||||||||||||||||||||
| Hemoglobin F |
|
|||||||||||||||||||||
| Hemoglobin A |
|
|||||||||||||||||||||
| Hemoglobin A2 |
|
Interpretive Data
Hemoglobin Evaluation:
HPLC Report: Results from HPLC are reported. Results were confirmed by capillary electrophoresis.
See CE Report: Results from capillary electrophoresis are reported under Hemoglobin Evaluation by Capillary Electrophoresis (3017102). Results were confirmed by HPLC.
Sickle Cell Solubility Reflex:
Not Performed: Solubility testing for hemoglobin S not indicated.
Positive: Positive for hemoglobin S by HPLC and confirmed by solubility testing.
Conf Previous: Positive for hemoglobin S by HPLC. Solubility testing performed previously and not repeated with this submission.
Modified FDA
Note
HPLC and capillary electrophoresis are performed on all samples. If a hemoglobin variant cannot be quantitated by HPLC, results from capillary electrophoresis will be reported.
If abnormal peaks suggestive of a sickling hemoglobin variant are detected, then RBC solubility will be performed. Additional charges apply.
Hotline History
Hotline History
CPT Codes
83021; 83020; if reflexed, add 85660
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3005529 | Hemoglobin A | 4547-6 |
| 3005665 | Hemoglobin A2 | 4551-8 |
| 3005666 | Hemoglobin F | 4576-5 |
| 3005667 | Hemoglobin S | 4625-0 |
| 3005668 | Hemoglobin C | 4563-3 |
| 3005669 | Hemoglobin E | 4575-7 |
| 3005670 | Hemoglobin Other | 48343-8 |
| 3005673 | Sickle Cell Solubility Reflex | 6864-3 |
| 3020927 | Hemoglobin Evaluation | 21026-0 |
Aliases
- Evaluation, Hemoglobin
- Fetal Hemoglobin
- Hemoglobin F
- Hb
- Hb ELP
- Hb IEF
- Hemoglobin Evaluation
- Hemoglobin Fractionation
- Hemoglobinopathy Fractionation Profile
- Hgb
- Sickle Cell Anemia Screen
- Sickle Cell Disease
- Sickle Cell Screen
- Hemoglobinopathy
- Hemoglobinopathies
















